Navigation Links
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Date:10/22/2010

Warner Chilcott Announces FDA Approval of New Oral Contraceptive -- ARDEE, Ireland, Oct. 22 /PRNewswire-FirstCall/ --
'/>"/>

SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
2. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
3. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
4. Warner Chilcott Announces FDA Approval of Next Generation Actonel
5. Warner Chilcott Announces the Closing of its $500 Million Senior Notes Offering
6. Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex®
7. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
8. Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex®
9. Warner Chilcott to Present at UBS Global Life Sciences Conference
10. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
11. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)...  Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... unmet needs in oncology, autoimmune and inflammatory disease, today ... closing of the NASDAQ Global Market on Tuesday, August ... by Michael Martino , president and CEO, and ... the same day at 5:00 pm EDT (2:00 pm ...
(Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
(Date:7/29/2014)... 2014 DailyGossip.org reveals in its latest review ... who can perfectly understand patients and what they have to ... Gadsby is the author of the new program. Ellie claims ... of suffering, Ellie started her very own research. Four years ... The author of the Get Rid of Cold Sores program ...
(Date:7/29/2014)... Daily Gossip indicates in its Natural ... created by a popular nutritionist and health specialist. Michael ... for this disorder, but none of them worked. , ... of having to look for an alternative vitiligo treatment, ... this method, too, to become vitiligo free. , ...
(Date:7/29/2014)... 2014 For survivors of severe combat injuries threatening ... flaps have a good record of safety and effectiveness ... issue of Plastic and Reconstructive Surgery ... Society of Plastic Surgeons (ASPS). , Experience with ... and Afghanistan shows good success rates, with no increase ...
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Although the bite of ... heal well if left alone, an expert notes. ... an adverse reaction to a brown recluse spider bite, ... Poison Center, particularly since these potentially dangerous bites are ... for us to do nothing. The [bite] has classic ...
(Date:7/29/2014)... NH (July 29, 2014) Using quality improvement measures ... New England Cardiovascular Disease Study Group, researchers have found ... a procedure with contrast dye. , Currently, 7-15 percent ... with contrast-dye end up with kidney injury, which can ... leading to temporary or permanent dialysis, says a study ...
Breaking Medicine News(10 mins):Health News:Get Rid of Cold Sores Fast Review Exposes the Way to Stop Outbreaks 2Health News:Natural Vitiligo Treatment System Review Reveals Michael Dawson’s New Vitiligo Cure Program 2Health News:Good outcomes with multiple limb salvage after severe combat injuries, reports Plastic and Reconstructive Surgery 2Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Reducing kidney injury using a quality improvement method 2
... Doctor, Health officials of the NHS Grampian said that people ... // The NHS health board said so defending their decision ... wards. ,A spokeswoman for NHS Grampian said a ... be suitable for a patient to stay outwith the city's ...
... is a fungal infection affecting mostly children in North America. ... affected by ringworm infections. //It is a highly contagious skin ... symptoms such as scaly scalp and hair loss which can ... household pets but in rare occasions it is passed easily ...
... The authorities in Delhi have blamed the poor quality of ... the last four months. So far 222 cases have been ... against 92 in the corresponding period last year. But we ... well under control," said N.K. Yadav, deputy municipal health officer ...
... Zealand have warned against using traditional Indian medicines after ... reported Friday.// ,"We wish to alert the medical ... a particular form of herbal remedy, namely, Ayurvedic medicine," ... Zealand Medical Journal. ,The eight patients suffered ...
... Delhi High Court has demanded an explanation from the medical ... boy suffering from cancer got inflicted with AIDS after undergoing ... an explanation on why the relevant documents were not being ... Sen ruled that the blood transfusion was the business of ...
... In the event of an influenza pandemic set into action by ... are we to handle// a mega crisis, and what plan of ... the responses to an epidemic, eight Asia Pacific countries are teaming ... gauge the effectiveness of a global response to a pandemic. ...
Cached Medicine News:
ELISA for detection of Anti-Gliadin IgA....
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Enzyme immunoassay for the quantitative determination of Gliadin-IgA antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
Medicine Products: